Evaluation of ICP-B208 in Patients With Advanced Solid Tumors

Clinical trial NCT07617493 · RECRUITING

Trial details

NCT number: NCT07617493
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2026-07-03
Primary completion: 2030-12-01
Enrollment: 539

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.